CTVA · Full Picture

Corteva, Inc. — the full picture

Trailing window · 2026-05-11 to 2026-08-09

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Revenue Performance and Mix · Revenue growth & mixPriority 71
    -121.5% revenue (realized); quote_verified
    Historical Corteva net sales for the year ended December 31, 2024 were $16,908 million.
  2. Liquidity and Debt Position · Debt, leverage & refinancingPriority 69
    13 forward row(s); quote_verified
    PHI expects to enter into a PHI Bilateral Facility up to an aggregate principal amount between $3,000 and $3,500 million.
  3. Operating Expense Trends · Operating expenses (SG&A)Priority 66
    +175.6% operating_income (realized); quote_verified
    Significant items (benefit) charge for Year Ended December 31, 2025 was $650 million.
  4. Acquisition / Partnership / Divestiture · M&A and divestituresPriority 64
    2 sources (news, press_release); quote_verified
    The distribution ratio for the Separation is one share of Vylor common stock for each share of Corteva common stock for basic and diluted, respectively.
  5. Outstanding Indebtedness · Debt, leverage & refinancingPriority 54
    2 forward row(s); quote_verified
    The outstanding senior notes of EIDP total $1.6 billion in preparation for the separation of its seed business into Vylor.
  6. Restructuring and Separation Costs · Restructuring & impairmentPriority 48
    -2.1% operating_income; 1 forward row(s); quote_verified
    Vylor expects to incur approximately $270 million of selling, general and administrative separation-related expenses which have not yet been recognized as of the period presented.
  7. Accrued Legal and Regulatory · Regulatory action & investigationsPriority 45
    1 forward row(s); quote_verified
    A federal judge approved over $2.5 billion in settlements between New Jersey and companies including DuPont, Chemours, Corteva, and 3M resolving claims related to PFAS pollution.
  8. Litigation and Legal Risk · Litigation & settlementsPriority 41
    quote_verified
    California Attorney General Rob Bonta filed a Second Amended Complaint alleging DuPont, Corteva, Chemours, and Qnity Electronics engaged in a corporate restructuring scheme to shift liabilities onto Chemours in violation of uniform fraudulent transfer acts.
  9. Guidance / Outlook · Guidance & outlookPriority 39
    1 forward row(s); quote_verified
    Corteva raised its full-year operating EPS guidance to US$3.60–US$3.80.
  10. Interest Rate and Refinancing Exposure · Interest ratesPriority 33
    -0.2% net_income (realized); 2 forward row(s); quote_verified
    Summary of debt pro forma shows Capital Markets Indebtedness aggregate principal amount $1,156 million at 5.23% producing $16 million pro forma interest for the three months ended March 31, 2026 and $62 million for year ended December 31, 2025.
  11. Regulatory Approval Milestones · Regulatory action & investigationsPriority 30
    qualitative only
  12. Income Tax Rate Changes · TaxPriority 28
    quote_verified
    The pro forma adjustments recorded approximately $156 million, net, within other current assets related to pre-Separation tax liabilities and receivables per the Tax Matters Agreement.

Threads by pillar

Revenue & Demand Priority 71 · 1 thread

Costs & Margins Priority 69 · 2 threads

Capital & Balance Sheet Priority 72 · 3 threads

Strategy & Portfolio Priority 64 · 1 thread

Legal, Regulatory & Policy Priority 51 · 3 threads

Guidance & Outlook Priority 39 · 1 thread

Macro & Market Conditions Priority 33 · 1 thread

Expected impact by metric

metricforward netforward grossrealized
operating_income-2.1%+2.1%+174.8%
net_income——-4.8%
revenue——-121.5%